Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dony Patel

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
BMC Infectious Diseases|February 5, 2025
A population-based study on the burden of hospitalized pediatric pneumococcal disease in Taiwan before and after the introduction of 13-valent pneumococcal conjugate vaccine into the childhood immunization program in 2015Ting-An Yen, Jhong-Lin Wu, Chi-Chuan Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Characteristics, treatment patterns, and survival among ALK+ non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review studyJacques Cadranel, Keunchil Park, Oscar Arrieta, et al.
Future Oncology (London, England)|November 17, 2021
Initial treatment and survival in Danish patients diagnosed with non-small-cell lung cancer (2005-2015): SCAN-LEAF studyJens Benn Sørensen, Pia Horvat, Mats Rosenlund, et al.
Lung Cancer Management|June 4, 2021
Treatment and outcomes for early non-small-cell lung cancer: a retrospective analysis of a Portuguese hospital databaseMarta Soares, Luís Antunes, Patrícia Redondo, et al.
BMC Pulmonary Medicine|September 11, 2020
Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiativeMarta Soares, Luís Antunes, Patrícia Redondo, et al.
Clinical and Experimental Rheumatology|March 31, 2018
The burden of systemic juvenile idiopathic arthritis for patients and caregivers: an international survey and retrospective chart reviewSusan Shenoi, Gerd Horneff, Michal Cidon, et al.
Asia-Pacific Journal of Clinical Oncology|April 19, 2017
Characteristics and outcomes of ALK+ non-small cell lung cancer patients in KoreaSung Hee Lim, Kyung Ah Yoh, Jong Seok Lee, et al.
JAMA Network Open|February 9, 2024
Epidemiology and Outcomes of Non-Small Cell Lung Cancer in South KoreaHyun Ae Jung, Dae Ho Lee, Sun Min Lim, et al.
Translational Lung Cancer Research|March 11, 2026
Molecular epidemiology and outcomes of <i>EGFR</i> exon 20 insertion in Korean patients with non-small cell lung cancerShinkyo Yoon, Seong-Eun Kim, Sun Min Lim, et al.
Tuberculosis (Edinburgh, Scotland)|April 13, 2011
Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agentsKathryn E A Lougheed, Simon A Osborne, Barbara Saxty, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
BMC Infectious Diseases|February 5, 2025
A population-based study on the burden of hospitalized pediatric pneumococcal disease in Taiwan before and after the introduction of 13-valent pneumococcal conjugate vaccine into the childhood immunization program in 2015Ting-An Yen, Jhong-Lin Wu, Chi-Chuan Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Characteristics, treatment patterns, and survival among ALK+ non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review studyJacques Cadranel, Keunchil Park, Oscar Arrieta, et al.
Future Oncology (London, England)|November 17, 2021
Initial treatment and survival in Danish patients diagnosed with non-small-cell lung cancer (2005-2015): SCAN-LEAF studyJens Benn Sørensen, Pia Horvat, Mats Rosenlund, et al.
Lung Cancer Management|June 4, 2021
Treatment and outcomes for early non-small-cell lung cancer: a retrospective analysis of a Portuguese hospital databaseMarta Soares, Luís Antunes, Patrícia Redondo, et al.
BMC Pulmonary Medicine|September 11, 2020
Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiativeMarta Soares, Luís Antunes, Patrícia Redondo, et al.
Clinical and Experimental Rheumatology|March 31, 2018
The burden of systemic juvenile idiopathic arthritis for patients and caregivers: an international survey and retrospective chart reviewSusan Shenoi, Gerd Horneff, Michal Cidon, et al.
Asia-Pacific Journal of Clinical Oncology|April 19, 2017
Characteristics and outcomes of ALK+ non-small cell lung cancer patients in KoreaSung Hee Lim, Kyung Ah Yoh, Jong Seok Lee, et al.
JAMA Network Open|February 9, 2024
Epidemiology and Outcomes of Non-Small Cell Lung Cancer in South KoreaHyun Ae Jung, Dae Ho Lee, Sun Min Lim, et al.
Translational Lung Cancer Research|March 11, 2026
Molecular epidemiology and outcomes of <i>EGFR</i> exon 20 insertion in Korean patients with non-small cell lung cancerShinkyo Yoon, Seong-Eun Kim, Sun Min Lim, et al.
Tuberculosis (Edinburgh, Scotland)|April 13, 2011
Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agentsKathryn E A Lougheed, Simon A Osborne, Barbara Saxty, et al.
Pageof 3